. Author manuscript; available in PMC: 2022 May 1.

Published in final edited form as: Clin Lung Cancer. 2021 Jan 10;22(3):187–194.e1. doi: 10.1016/j.cllc.2021.01.001

Table 1:

Demographics and tumor characteristics in FEP and PAP

	Full Eligible Patients (FEP) (N=47)	Primary Analysis Population (PAP) (N=24^*)
Age Median (Range)	66.7 (37.5-82.1)	68 (41.8-82)
Male Gender	39 (83%)	21 (88%)
Performance Status
0	10 (21%)	6 (25%)
1	37 (79%)	18 (75%)
Race/Ethnicity
White	40 (85%)	22 (92%)
Black	7 (15%)	2 (8%)
Hispanic ethnicity
Yes	2 (4%)	2 (8%)
No	44 (94%)	21 (88%)
Unknown	1 (2%)	1 (4%)
Number of Prior Lines of Therapy For Stage IV Disease
0	11 (23%)	5 (21%)
1	13 (28%)	7 (29%)
2 or more	23 (49%)	12 (50%)
Smoking Status
Current Smoker	7 (15%)	5 (21%)
Recent Smoker	8 (17%)	3 (13%)
Former Smoker	31 (66%)	15 (63%)
Never smoker	1 (2%)	1 (4%)

: three of 27 patients assigned to the study did not start treatment